NCT00451048 2018-09-04Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Completed10 enrolled 9 charts
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled